Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by henery345


V.HEM

$HMTXF efficacy treating capacity of NCP-01 by Hemostemix

Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem...

June 17, 2022

V.HEM

Hemostemix announce about closing of $2,750,000

Hemostemix Inc. has announced that it has closed its previously announced $2...

June 10, 2022

V.HEM

$HMTXF get backs all its intellectual property

Hemostemix is now in possession of all of its intellectual property...

June 10, 2022

V.HEM

Hemostemix owns over 91 patents

The Company owns 91 patents across five patent families titled: Regulating...

June 10, 2022

V.HEM

Hemostemix being a winner of World Economic Forum Technology

Hemostemix is a publicly traded autologous stem cell therapy company, founded...

June 8, 2022

V.HEM

Hemostemix owns over 91 patents

The Company owns 91 patents across five patent families titled: Regulating...

June 8, 2022

Featured Company